In one paragraphArticle in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Mara CarreñoDepartment of Pathology, School of Medicine, The University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-7246-4248 Diane LenhartDepartment of Medicine, Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA.
Rajat PantDepartment of Medicine, Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA.
Paritosh MondalDepartment of Medicine, Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA.
Sonia R SalvatoreDepartment of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-9942-3905 Maria F PiresDepartment of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-9343-856X Enrico M NovelliDepartment of Medicine, Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0003-3010-8285 Francisco J SchopferDepartment of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-9526-695X Samit GhoshDepartment of Medicine, Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-3536-3077 Dario A VitturiDepartment of Pathology, School of Medicine, The University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0003-0354-4567 Funding
Molecular and Cellular Pathogenesis of Kidney Disease in Sickle Cell DisordersR01DK124426 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Samit Ghosh · 2022 to 2024
$1.0MFormation, metabolism and cell signaling actions of tryptophan catabolism-derived electrophilesR35GM152083 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2024 to 2025
$743kRenal endothelium and the development of chronic kidney disease in sickle cell disordersR01DK132145 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$628kNHLBI NIH HHS K01 HL133331NHLBI NIH HHS R03 HL157878NIAID NIH HHS R01 AI178864NIAID NIH HHS R56 AI165479NIDDK NIH HHS R01 DK124426NIDDK NIH HHS R01 DK132145NIGMS NIH HHS R35 GM152083
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID40117493
PMCPMC12180981
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390